CDM THERAPY
Timeline
7 events since 2023Filings
Financial
Establishments
2023202420252026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBmicro format · 4 days before the deadline
2025
Highest result from 2023 to 2025 net €22,241 ▲18.4% The operating result of €28,610 and the net result of €22,241 are both a record.
Liquidity more than doubled current ratio 19.92 The current ratio rises from 6.89 to 19.92. Short-term debt falls from €6,090 to €3,124.
Annual accounts 2024 filed PDFmicro format · 44 days before the deadline
2024
Annual accounts 2023 filed PDFmicro format · 9 days before the deadline
2023
IncorporationFounding capital of €3,000, 100 shares · Founder: DE MARCO Cyril Raymond Stéphane · Appointment: DE MARCO Cyril Raymond Stéphane (director) · published on 31-03-20235 points ▸
- Founder, DE MARCO Cyril Raymond Stéphane
- Founding capital, €3,000, 100 shares
- 100 shares
- Registered office clause, Rue vieille Eglise 16, 4860 Cornesse (Pepinster)
- Director appointment, DE MARCO Cyril Raymond Stéphane (director (not named in the articles))
- The deed holds 5 more points.
First establishment Vieille Eglise 16, Pepinster
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
CDM THERAPY was incorporated on 29 March 2023 as a private limited company by one natural person, with a starting capital of €3,000.12 DE MARCO Cyril Raymond Stéphane is director of the company, appointed by deed of 31-03-2023.2 Total assets rose from €32,468 in 2023 to €68,081 in 2025.3